Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
about
Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 October 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@en
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@nl
type
label
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@en
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@nl
prefLabel
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@en
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@nl
P2093
P50
P1476
Safety and Efficacy of Pazopan ...... nal Failure: CORE-URO-01 Study
@en
P2093
Annalisa Berselli
Annalisa Guida
Carmine Pinto
Cristina Masini
Francesca Vignani
Giuseppe Prati
Giuseppe Procopio
Laura Cosmai
Marco Maruzzo
Maria Giuseppa Vitale
P304
P356
10.1016/J.CLGC.2018.10.001
P407
P577
2018-10-10T00:00:00Z